The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Do continued antidepressants protect against dementia in patients with severe depressive disorder?
Abstract
Studies on humans show that depressive disorder is associated with an increased risk of developing cognitive dysfunction, and animal studies suggest that antidepressants may have neuroprotective abilities. On the basis of these observations, it was hypothesized that treatment with antidepressants may decrease the risk of developing dementia in patients with depression. We investigated whether continued treatment with antidepressants is associated with a decreased rate of dementia in a population of patients discharged from psychiatric healthcare service with a diagnosis of depression. We used register data on all prescribed antidepressants in all patients discharged from psychiatric healthcare service with a diagnosis of depression and with subsequent diagnoses of dementia in Denmark from 1995 to 2005. A total of 37 658 patients with a diagnosis of depression at their first psychiatric contact and who were exposed to antidepressants after discharge were included in the study. A total of 2007 patients (5.3%) were subsequently diagnosed with dementia of any kind. The rate of dementia decreased during periods of two or more prescriptions of older antidepressants compared with the period of only one prescription of older antidepressants [relative risk (RR)=0.83 (95% confidence interval (CI)=0.70-0.98)]. This finding was replicated with Alzheimer's disease as the outcome [RR=0.66 (95% CI=0.47-0.94)] but not with dementia of other kinds as the outcome [RR=0.88 (95% CI=0.73-1.06)].…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Studies investigating the relationship between antidepressant use and AD/ADRD risk have yielded conflicting results.
“Studies looking into this question, however, have yielded conflicting results. 4-7”
From Antidepressant exposure and long‐term dementia risk in a nationwide retrospective study on US veterans with midlife major depressive disorder (2024) · cites this paper as [4]
Citations
Cites
Kessing, L. V., Søndergård, L., Forman, J. L., & Andersen, P. K. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.11.020 · Cited by 113 · cited 14×
“, 2008) and antidepressants and dementia (Kessing et al., 2009), used the same kind of analyses.”
BackgroundResultInfluentialSelf-citation
Flagged first, then by citations
Cited by
Sorted by citations
Depression—an underrecognized target for prevention of dementia in Alzheimer’s disease
Dafsari, F. S., & Jessen, F. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0839-1 · Cited by 312
Bartels, C., Wagner, M., Wolfsgruber, S., Ehrenreich, H., Schneider, A., & Initiative, F. T. A. D. N. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.17040404 · Cited by 202
Herbert, J., & Lucassen, P. J. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2015.12.001 · Cited by 150
Chan, J. Y. C., Yiu, K. K. L., Kwok, T. C. Y., Wong, S. Y. S., & Tsoi, K. K. F. (2019) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2018.12.004 · Cited by 135
Enhanced Molecular Aging in Late-Life Depression: the Senescent-Associated Secretory Phenotype
Diniz, B. S., Reynolds, C. F., Sibille, E., Lin, C.-W., Tseng, G., Lotrich, F., Aizenstein, H. J., & Butters, M. A. (2017) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2016.08.018 · Cited by 73
Serotonin, β‐amyloid, and cognition in Parkinson disease
Kotagal, V., Spino, C., Bohnen, N. I., Koeppe, R., & Albin, R. L. (2018) · Annals of Neurology · doi:10.1002/ana.25236 · Cited by 64
Cumulative Antidepressant Use and Risk of Dementia in a Prospective Cohort Study
Heath, L., Gray, S. L., Boudreau, D. M., Thummel, K., Edwards, K. L., Fullerton, S. M., Crane, P. K., & Larson, E. B. (2018) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15508 · Cited by 41
Ramos‐Cejudo, J., Corrigan, J. K., Zheng, C., Swinnerton, K. N., Jacobson, S. R., La, J., Betensky, R. A., Osorio, R. S., Madanes, S., Pomara, N., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13853 · Cited by 11
Risk of dementia among antidepressant elderly users: A population-based cohort analysis in Spain
Santandreu, J., Caballero, F. F., Gómez-Serranillos, M. P., & González-Burgos, E. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.01.002 · Cited by 3
Metadata
- Authors
- Kessing, L. V., Forman, J. L., & Andersen, P. K.
- Affiliations
- Copenhagen University Hospital (DK)
- University of Copenhagen (DK)
- Corresponding author
- Kessing, Lars Vedel
- Venue
- International Clinical Psychopharmacology
- Published
- 2011-11
- Volume
- 26
- Issue
- 6
- Pages
- 316-322
- ISSN
- 0268-1315 (ISSN-L)
- OpenAlex
- W2085892085
- Cited by
- 74
- References
- 1
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 7 · 2023: 3 · 2022: 4 · 2021: 2 · 2020: 6 · 2019: 7 · 2018: 3 · 2017: 6 · 2016: 7 · 2015: 8 · 2014: 9 · 2013: 2 · 2012: 5
- FWCI
- 3.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Clinical Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- antidepressants, dementia, long-term antidepressant treatment, Alzheimer's disease, selective serotonin reuptake inhibitors, neuroprotection, cognitive impairment, psychiatric hospital discharge
- MeSH terms
- Aged, Alzheimer Disease, Antidepressive Agents, Dementia, Denmark, Depressive Disorder, Female, Hospitals, Humans, Inpatients, Male, Middle Aged, Outpatients, Registries, Risk, Comorbidity, Treatment Outcome, Selective Serotonin Reuptake Inhibitors, Disease Progression, Neuroprotective Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review